The North America Automated Cell Counting Market would witness market growth of 11.5% CAGR during the forecast period (2023-2030).
Automated cell counters are statistical instruments utilized in pharmaceutical research, medical diagnostics, and food quality control to quantify and analyze cells. These employ sophisticated methodologies such as flow cytometry and digital imaging to facilitate meticulous and uniform cell examination. The market stands at the forefront of transformative advancements in life sciences, offering a pivotal range of sophisticated instruments and technologies that revolutionize cell analysis.
Automated cell counting represents a critical nexus between technological sophistication and the pursuit of more profound insights into cellular biology. These instruments encompass a diverse array of tools, from flow cytometers to image-based cell counters and automated haematology analysers, each designed to streamline and enhance the analysis of cells across various applications and industries. Defined by cutting-edge innovation, precision, and efficiency, this market caters to the burgeoning demands of scientific research, clinical diagnostics, pharmaceutical developments, and therapeutic innovations.
The increasing incidence of chronic ailments, including diabetes, cancer, and cardiovascular diseases, is a significant catalyst for expanding the market. Continuous monitoring and diagnosis of blood cell counts is necessary for chronic diseases, which increases the use of automated cell counters. According to the Centres for Disease Control and Prevention, the United States' fifth and first primary causes of death, respectively, are heart disease and stroke. Consequently, the increasing prevalence of chronic diseases in the region drives the demand in the market.
The US market dominated the North America Automated Cell Counting Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,186.8 million by 2030. The Canada market is experiencing a CAGR of 14% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 13% during (2023 - 2030).
Based on Product, the market is segmented into Consumables Accessories, and Instruments (Image-based Cell Counters, Flow Cytometers, Electrical Impendence Coulter Counters). Based on Application, the market is segmented into Cell Line development, Blood Analysis, Stem Cell Research, and Others. Based on End-use, the market is segmented into Pharmaceutical Biotechnology Companies, Hospitals Diagnostic laboratories, Research Academic Institutes, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Automated Cell Counting Market is Predict to reach USD 8.6 Billion by 2030, at a CAGR of 12.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
By Product
By Application
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
